North America Clinical Chemistry Market Outlook to 2024

Published : Dec-2017

No. of Pages : 410

order by fax Inquire before Buying request discount

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 7
2 Introduction 10
2.1 What Is This Report About? 10
2.2 Clinical Chemistry Market Segmentation 10
2.3 Definitions of Markets Covered in the Report 12
3 Clinical Chemistry Market, North America 17
3.1 Clinical Chemistry Market, North America, Revenue ($m), 2010-2024 17
3.2 Clinical Chemistry Market, North America, Category Comparison by Revenue ($m), 2010-2024 19
3.3 Clinical Chemistry Market, North America, Revenue ($m), 2010-2017 21
3.4 Clinical Chemistry Market, North America, Revenue ($m), 2017-2024 23
3.5 Clinical Chemistry Market, North America, Volume (Units), 2010-2024 25
3.6 Clinical Chemistry Market, North America, Volume (Units), 2010-2017 27
3.7 Clinical Chemistry Market, North America, Volume (Units), 2017-2024 29
3.8 Clinical Chemistry Market, North America, Company Share by Revenue ($m), 2017 31
4 Clinical Chemistry Market, Canada 33
4.1 Clinical Chemistry Market, Canada, Revenue ($m), 2010-2017 33
4.2 Clinical Chemistry Market, Canada, Revenue ($m), 2017-2024 35
4.3 Clinical Chemistry Market, Canada, Volume (Units), 2010-2017 69
4.4 Clinical Chemistry Market, Canada, Volume (Units), 2017-2024 71
4.5 Clinical Chemistry Market, Canada, Average Price ($), 2010-2024 97
4.6 Clinical Chemistry Market, Canada, Distribution Share by Revenue ($m), 2017 103
4.7 Clinical Chemistry Market, Canada, Company Share by Revenue ($m), 2017 104
5 Clinical Chemistry Market, Mexico 106
5.1 Clinical Chemistry Market, Mexico, Revenue ($m), 2010-2017 106
5.2 Clinical Chemistry Market, Mexico, Revenue ($m), 2017-2024 108
5.3 Clinical Chemistry Market, Mexico, Volume (Units), 2010-2017 142
5.4 Clinical Chemistry Market, Mexico, Volume (Units), 2017-2024 144
5.5 Clinical Chemistry Market, Mexico, Average Price ($), 2010-2024 170
5.6 Clinical Chemistry Market, Mexico, Distribution Share by Revenue ($m), 2017 176
5.7 Clinical Chemistry Market, Mexico, Company Share by Revenue ($m), 2017 177
6 Clinical Chemistry Market, United States 179
6.1 Clinical Chemistry Market, United States, Revenue ($m), 2010-2017 179
6.2 Clinical Chemistry Market, United States, Revenue ($m), 2017-2024 181
6.3 Clinical Chemistry Market, United States, Volume (Units), 2010-2017 215
6.4 Clinical Chemistry Market, United States, Volume (Units), 2017-2024 217
6.5 Clinical Chemistry Market, United States, Average Price ($), 2010-2024 243
6.6 Clinical Chemistry Market, United States, Distribution Share by Revenue ($m), 2017 249
6.7 Clinical Chemistry Market, United States, Company Share by Revenue ($m), 2017 250
7 Overview of Key Companies in North America Clinical Chemistry Market 252
7.1 F. Hoffmann-La Roche Ltd 252
7.2 Beckman Coulter Inc 252
7.3 Abbott Laboratories 252
7.4 Ortho-Clinical Diagnostics Inc 252
7.5 Siemens Healthcare GmbH 253
7.6 Thermo Fisher Scientific Inc 253
7.7 bioMerieux SA 253
7.8 Alere Inc 253
7.9 Medline Industries Inc 254
7.10 Mindray Medical International Ltd 254
7.11 Meridian Bioscience Inc 254
7.12 DiaSorin S.p.A 254
7.13 Randox Laboratories Ltd 255
7.14 Hitachi Ltd 255
7.15 Orion Diagnostica Oy 255
8 Clinical Chemistry Market Pipeline Products 256
9 Recent Developments 258
9.1 Corporate Communications 258
9.2 Financial Announcements 285
9.3 Government and Public Interest 378
9.4 Legal And Regulatory 379
9.5 Other Significant Developments 383
9.6 Product News 388
9.7 Strategy And Business Planning 396
10 Appendix 398
10.1 Research Methodology 399
10.2 GlobalData Consulting 403
10.3 Contact Us 404
10.4 Disclaimer 404

1.1 List of Tables
Table 1: Clinical Chemistry Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2010-2024 24
Table 2: Clinical Chemistry Market, North America, Category Comparison by Revenue ($m), USD Constant, 2010-2024 26
Table 3: Clinical Chemistry Market, North America, Revenue ($m), Historic, USD Constant, 2010-2017 28
Table 4: Clinical Chemistry Market, North America, Revenue ($m), Forecast, USD Constant, 2017-2024 30
Table 5: Clinical Chemistry Market, North America, Volume (Units), 2010-2024 32
Table 6: Clinical Chemistry Market, North America, Volume (Units), Historic, 2010-2017 34
Table 7: Clinical Chemistry Market, North America, Volume (Units), Forecast, 2017-2024 36
Table 8: Clinical Chemistry Market, North America, Company Share by Revenue ($m), USD Constant, 2017 38
Table 9: Clinical Chemistry Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 40
Table 10: Clinical Chemistry Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 42
Table 11: Blood Test Strips - Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 44
Table 12: Clinical Chemistry Analyzers Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 46
Table 13: Enzyme Chemistry Reagents Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 48
Table 14: Feces Tests - Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 50
Table 15: Substrates Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 52
Table 16: Therapeutic Drug Monitoring Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 54
Table 17: Urine Analysis Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 56
Table 18: Urine Testing - Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 58
Table 19: Blood Test Strips - Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 60
Table 20: Clinical Chemistry Analyzers Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 62
Table 21: Enzyme Chemistry Reagents Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 64
Table 22: Feces Tests - Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 66
Table 23: Substrates Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 68
Table 24: Therapeutic Drug Monitoring Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 70
Table 25: Urine Analysis Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 72
Table 26: Urine Testing - Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 74
Table 27: Clinical Chemistry Market, Canada, Volume (Units), Historic, 2010-2017 76
Table 28: Clinical Chemistry Market, Canada, Volume (Units), Forecast, 2017-2024 78
Table 29: Blood Test Strips - Rapid Tests & POC Market, Canada, Volume (Units), Historic, 2010-2017 80
Table 30: Clinical Chemistry Analyzers Market, Canada, Volume (Units), Historic, 2010-2017 82
Table 31: Enzyme Chemistry Reagents Market, Canada, Volume (Units), Historic, 2010-2017 84
Table 32: Feces Tests - Rapid Tests & POC Market, Canada, Volume (Units), Historic, 2010-2017 86
Table 33: Substrates Market, Canada, Volume (Units), Historic, 2010-2017 88
Table 34: Urine Testing - Rapid Tests & POC Market, Canada, Volume (Units), Historic, 2010-2017 90
Table 35: Blood Test Strips - Rapid Tests & POC Market, Canada, Volume (Units), Forecast, 2017-2024 92
Table 36: Clinical Chemistry Analyzers Market, Canada, Volume (Units), Forecast, 2017-2024 94
Table 37: Enzyme Chemistry Reagents Market, Canada, Volume (Units), Forecast, 2017-2024 96
Table 38: Feces Tests - Rapid Tests & POC Market, Canada, Volume (Units), Forecast, 2017-2024 98
Table 39: Substrates Market, Canada, Volume (Units), Forecast, 2017-2024 100
Table 40: Urine Testing - Rapid Tests & POC Market, Canada, Volume (Units), Forecast, 2017-2024 102
Table 41: Clinical Chemistry Market, Canada, Average Price ($) Historic, 2010-2017 103
Table 42: Clinical Chemistry Market, Canada, Average Price ($), Forecast, 2017-2024 106
Table 43: Clinical Chemistry Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2017 109
Table 44: Clinical Chemistry Market, Canada, Company Share by Revenue ($m), USD Constant, 2017 111
Table 45: Clinical Chemistry Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 113
Table 46: Clinical Chemistry Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 115
Table 47: Blood Test Strips - Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 117
Table 48: Clinical Chemistry Analyzers Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 119
Table 49: Enzyme Chemistry Reagents Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 121
Table 50: Feces Tests - Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 123
Table 51: Substrates Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 125
Table 52: Therapeutic Drug Monitoring Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 127
Table 53: Urine Analysis Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 129
Table 54: Urine Testing - Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 131
Table 55: Blood Test Strips - Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 133
Table 56: Clinical Chemistry Analyzers Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 135
Table 57: Enzyme Chemistry Reagents Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 137
Table 58: Feces Tests - Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 139
Table 59: Substrates Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 141
Table 60: Therapeutic Drug Monitoring Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 143
Table 61: Urine Analysis Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 145
Table 62: Urine Testing - Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 147
Table 63: Clinical Chemistry Market, Mexico, Volume (Units), Historic, 2010-2017 149
Table 64: Clinical Chemistry Market, Mexico, Volume (Units), Forecast, 2017-2024 151
Table 65: Blood Test Strips - Rapid Tests & POC Market, Mexico, Volume (Units), Historic, 2010-2017 153
Table 66: Clinical Chemistry Analyzers Market, Mexico, Volume (Units), Historic, 2010-2017 155
Table 67: Enzyme Chemistry Reagents Market, Mexico, Volume (Units), Historic, 2010-2017 157
Table 68: Feces Tests - Rapid Tests & POC Market, Mexico, Volume (Units), Historic, 2010-2017 159
Table 69: Substrates Market, Mexico, Volume (Units), Historic, 2010-2017 161
Table 70: Urine Testing - Rapid Tests & POC Market, Mexico, Volume (Units), Historic, 2010-2017 163
Table 71: Blood Test Strips - Rapid Tests & POC Market, Mexico, Volume (Units), Forecast, 2017-2024 165
Table 72: Clinical Chemistry Analyzers Market, Mexico, Volume (Units), Forecast, 2017-2024 167
Table 73: Enzyme Chemistry Reagents Market, Mexico, Volume (Units), Forecast, 2017-2024 169
Table 74: Feces Tests - Rapid Tests & POC Market, Mexico, Volume (Units), Forecast, 2017-2024 171
Table 75: Substrates Market, Mexico, Volume (Units), Forecast, 2017-2024 173
Table 76: Urine Testing - Rapid Tests & POC Market, Mexico, Volume (Units), Forecast, 2017-2024 175
Table 77: Clinical Chemistry Market, Mexico, Average Price ($) Historic, 2010-2017 176
Table 78: Clinical Chemistry Market, Mexico, Average Price ($), Forecast, 2017-2024 179
Table 79: Clinical Chemistry Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2017 182
Table 80: Clinical Chemistry Market, Mexico, Company Share by Revenue ($m), USD Constant, 2017 184
Table 81: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 186
Table 82: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 188
Table 83: Blood Test Strips - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 190
Table 84: Clinical Chemistry Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 192
Table 85: Enzyme Chemistry Reagents Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 194
Table 86: Feces Tests - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 196
Table 87: Substrates Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 198
Table 88: Therapeutic Drug Monitoring Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 200
Table 89: Urine Analysis Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 202
Table 90: Urine Testing - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 204
Table 91: Blood Test Strips - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 206
Table 92: Clinical Chemistry Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 208
Table 93: Enzyme Chemistry Reagents Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 210
Table 94: Feces Tests - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 212
Table 95: Substrates Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 214
Table 96: Therapeutic Drug Monitoring Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 216
Table 97: Urine Analysis Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 218
Table 98: Urine Testing - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 220
Table 99: Clinical Chemistry Market, United States, Volume (Units), Historic, 2010-2017 222
Table 100: Clinical Chemistry Market, United States, Volume (Units), Forecast, 2017-2024 224
Table 101: Blood Test Strips - Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 226
Table 102: Clinical Chemistry Analyzers Market, United States, Volume (Units), Historic, 2010-2017 228
Table 103: Enzyme Chemistry Reagents Market, United States, Volume (Units), Historic, 2010-2017 230
Table 104: Feces Tests - Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 232
Table 105: Substrates Market, United States, Volume (Units), Historic, 2010-2017 234
Table 106: Urine Testing - Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 236
Table 107: Blood Test Strips - Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 238
Table 108: Clinical Chemistry Analyzers Market, United States, Volume (Units), Forecast, 2017-2024 240
Table 109: Enzyme Chemistry Reagents Market, United States, Volume (Units), Forecast, 2017-2024 242
Table 110: Feces Tests - Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 244
Table 111: Substrates Market, United States, Volume (Units), Forecast, 2017-2024 246
Table 112: Urine Testing - Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 248
Table 113: Clinical Chemistry Market, United States, Average Price ($) Historic, 2010-2017 249
Table 114: Clinical Chemistry Market, United States, Average Price ($), Forecast, 2017-2024 252
Table 115: Clinical Chemistry Market, United States, Distribution Share by Revenue ($m), USD Constant, 2016-2017 255
Table 116: Clinical Chemistry Market, United States, Company Share by Revenue ($m), USD Constant, 2017 257
Table 117: Clinical Chemistry Market Pipeline Products 262
Table 118: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 407

1.2 List of Figures
Figure 1: Clinical Chemistry Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2010-2024 23
Figure 2: Clinical Chemistry Market, North America, Category Comparison by Revenue ($m), USD Constant, 2010-2024 25
Figure 3: Clinical Chemistry Market, North America, Revenue ($m), Historic, USD Constant, 2010-2017 27
Figure 4: Clinical Chemistry Market, North America, Revenue ($m), Forecast, USD Constant, 2017-2024 29
Figure 5: Clinical Chemistry Market, North America, Volume (Units), 2010-2024 31
Figure 6: Clinical Chemistry Market, North America, Volume (Units), Historic, 2010-2017 33
Figure 7: Clinical Chemistry Market, North America, Volume (Units), Forecast, 2017-2024 35
Figure 8: Clinical Chemistry Market, North America, Company Share (%) 2017 37
Figure 9: Clinical Chemistry Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 39
Figure 10: Clinical Chemistry Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 41
Figure 11: Blood Test Strips - Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 43
Figure 12: Clinical Chemistry Analyzers Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 45
Figure 13: Enzyme Chemistry Reagents Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 47
Figure 14: Feces Tests - Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 49
Figure 15: Substrates Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 51
Figure 16: Therapeutic Drug Monitoring Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 53
Figure 17: Urine Analysis Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 55
Figure 18: Urine Testing - Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 57
Figure 19: Blood Test Strips - Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 59
Figure 20: Clinical Chemistry Analyzers Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 61
Figure 21: Enzyme Chemistry Reagents Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 63
Figure 22: Feces Tests - Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 65
Figure 23: Substrates Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 67
Figure 24: Therapeutic Drug Monitoring Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 69
Figure 25: Urine Analysis Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 71
Figure 26: Urine Testing - Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 73
Figure 27: Clinical Chemistry Market, Canada, Volume (Units), Historic, 2010-2017 75
Figure 28: Clinical Chemistry Market, Canada, Volume (Units), Forecast, 2017-2024 77
Figure 29: Blood Test Strips - Rapid Tests & POC Market, Canada, Volume (Units), Historic, 2010-2017 79
Figure 30: Clinical Chemistry Analyzers Market, Canada, Volume (Units), Historic, 2010-2017 81
Figure 31: Enzyme Chemistry Reagents Market, Canada, Volume (Units), Historic, 2010-2017 83
Figure 32: Feces Tests - Rapid Tests & POC Market, Canada, Volume (Units), Historic, 2010-2017 85
Figure 33: Substrates Market, Canada, Volume (Units), Historic, 2010-2017 87
Figure 34: Urine Testing - Rapid Tests & POC Market, Canada, Volume (Units), Historic, 2010-2017 89
Figure 35: Blood Test Strips - Rapid Tests & POC Market, Canada, Volume (Units), Forecast, 2017-2024 91
Figure 36: Clinical Chemistry Analyzers Market, Canada, Volume (Units), Forecast, 2017-2024 93
Figure 37: Enzyme Chemistry Reagents Market, Canada, Volume (Units), Forecast, 2017-2024 95
Figure 38: Feces Tests - Rapid Tests & POC Market, Canada, Volume (Units), Forecast, 2017-2024 97
Figure 39: Substrates Market, Canada, Volume (Units), Forecast, 2017-2024 99
Figure 40: Urine Testing - Rapid Tests & POC Market, Canada, Volume (Units), Forecast, 2017-2024 101
Figure 41: Clinical Chemistry Market, Canada, Company Share (%) 2017 110
Figure 42: Clinical Chemistry Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 112
Figure 43: Clinical Chemistry Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 114
Figure 44: Blood Test Strips - Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 116
Figure 45: Clinical Chemistry Analyzers Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 118
Figure 46: Enzyme Chemistry Reagents Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 120
Figure 47: Feces Tests - Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 122
Figure 48: Substrates Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 124
Figure 49: Therapeutic Drug Monitoring Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 126
Figure 50: Urine Analysis Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 128
Figure 51: Urine Testing - Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 130
Figure 52: Blood Test Strips - Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 132
Figure 53: Clinical Chemistry Analyzers Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 134
Figure 54: Enzyme Chemistry Reagents Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 136
Figure 55: Feces Tests - Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 138
Figure 56: Substrates Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 140
Figure 57: Therapeutic Drug Monitoring Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 142
Figure 58: Urine Analysis Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 144
Figure 59: Urine Testing - Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 146
Figure 60: Clinical Chemistry Market, Mexico, Volume (Units), Historic, 2010-2017 148
Figure 61: Clinical Chemistry Market, Mexico, Volume (Units), Forecast, 2017-2024 150
Figure 62: Blood Test Strips - Rapid Tests & POC Market, Mexico, Volume (Units), Historic, 2010-2017 152
Figure 63: Clinical Chemistry Analyzers Market, Mexico, Volume (Units), Historic, 2010-2017 154
Figure 64: Enzyme Chemistry Reagents Market, Mexico, Volume (Units), Historic, 2010-2017 156
Figure 65: Feces Tests - Rapid Tests & POC Market, Mexico, Volume (Units), Historic, 2010-2017 158
Figure 66: Substrates Market, Mexico, Volume (Units), Historic, 2010-2017 160
Figure 67: Urine Testing - Rapid Tests & POC Market, Mexico, Volume (Units), Historic, 2010-2017 162
Figure 68: Blood Test Strips - Rapid Tests & POC Market, Mexico, Volume (Units), Forecast, 2017-2024 164
Figure 69: Clinical Chemistry Analyzers Market, Mexico, Volume (Units), Forecast, 2017-2024 166
Figure 70: Enzyme Chemistry Reagents Market, Mexico, Volume (Units), Forecast, 2017-2024 168
Figure 71: Feces Tests - Rapid Tests & POC Market, Mexico, Volume (Units), Forecast, 2017-2024 170
Figure 72: Substrates Market, Mexico, Volume (Units), Forecast, 2017-2024 172
Figure 73: Urine Testing - Rapid Tests & POC Market, Mexico, Volume (Units), Forecast, 2017-2024 174
Figure 74: Clinical Chemistry Market, Mexico, Company Share (%) 2017 183
Figure 75: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 185
Figure 76: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 187
Figure 77: Blood Test Strips - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 189
Figure 78: Clinical Chemistry Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 191
Figure 79: Enzyme Chemistry Reagents Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 193
Figure 80: Feces Tests - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 195
Figure 81: Substrates Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 197
Figure 82: Therapeutic Drug Monitoring Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 199
Figure 83: Urine Analysis Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 201
Figure 84: Urine Testing - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 203
Figure 85: Blood Test Strips - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 205
Figure 86: Clinical Chemistry Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 207
Figure 87: Enzyme Chemistry Reagents Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 209
Figure 88: Feces Tests - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 211
Figure 89: Substrates Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 213
Figure 90: Therapeutic Drug Monitoring Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 215
Figure 91: Urine Analysis Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 217
Figure 92: Urine Testing - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 219
Figure 93: Clinical Chemistry Market, United States, Volume (Units), Historic, 2010-2017 221
Figure 94: Clinical Chemistry Market, United States, Volume (Units), Forecast, 2017-2024 223
Figure 95: Blood Test Strips - Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 225
Figure 96: Clinical Chemistry Analyzers Market, United States, Volume (Units), Historic, 2010-2017 227
Figure 97: Enzyme Chemistry Reagents Market, United States, Volume (Units), Historic, 2010-2017 229
Figure 98: Feces Tests - Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 231
Figure 99: Substrates Market, United States, Volume (Units), Historic, 2010-2017 233
Figure 100: Urine Testing - Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 235
Figure 101: Blood Test Strips - Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 237
Figure 102: Clinical Chemistry Analyzers Market, United States, Volume (Units), Forecast, 2017-2024 239
Figure 103: Enzyme Chemistry Reagents Market, United States, Volume (Units), Forecast, 2017-2024 241
Figure 104: Feces Tests - Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 243
Figure 105: Substrates Market, United States, Volume (Units), Forecast, 2017-2024 245
Figure 106: Urine Testing - Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 247
Figure 107: Clinical Chemistry Market, United States, Company Share (%) 2017 256

Filed in: In Vitro Diagnostic, Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026 “The global in vitro fertilization market size is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1 % during the forecast period” The global in vitro fertilization market is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1% from 2021 to 2026. The key factors fueling the growth of this market include an increase in the median age of first-time mothers, declining fertility rates, rising male infertility, rise in obesity rate and growing consumption of alcohol, and growing awareness about the availability of treatment options. However, the high cost and low success rate of IVF treatment and restrictive regulations and ethical concerns are expected to restrict the growth of the IVF market to a certain e......	$4950
Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact) Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) Summary Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within General Surgery therapeutic area. The model discusses in detail the impact of COVID-19 on Assisted Reproductive Technology Devices market for the year 2020 and beyond. Assisted Reproductive Technology (ART) refers to reproductive health procedures that treat infertile women to achieve pregnancy. For decades now across much of the developed world, several techniques of ART have been in use with varying pregnancy success rates. These techniques primarily include, but are no......	$7500
Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact) Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) Summary Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on Multiparameter CT/NG NAAT Tests market for the year 2020 and beyond. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia Trachomatis. In women, Chlamydia Trachomatis infections are often asymptomatic, however, if left untreated they can cause pelvic inflammatory disease (PID), which in turn can lead to additional complications such as infertility, ectopic preg......	$7500
Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028 Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028 Summary Hemophilia A and B are rare, genetic, X-linked deficiencies in the blood clotting factors VIII (FVIII) and IX (FIX), respectively. Patients can be categorized as mild, moderate or severe depending on the percentage of circulating FVIII or FIX in their blood. Patients can be treated either on-demand or prophylactically using plasma-derived or recombinant replacement factors, the current standard of care. Although these therapies are effective, they are associated with a great treatment burden. There is a significant unmet need for new therapies that can reduce the great treatment burden associated with intravenous administration, the frequency of prophylactic infusions, and the risk of developing neutralizing a......	$10995
Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Human Immunodeficiency Virus (HIV) has become one of the world's most serious health issues affecting approximately 36.9 million people. The epidemiology of HIV infections varies from one geographical region to another. Sources indicate that in many countries, incidence rates for HIV have stabilized due to the campaigns that provide condoms, pre-exposure prophylaxis, sterile needles, syringes, antiretroviral therapy (ART), and prevention of mother-to-child transmission interv......	$7500
Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia trachomatis. Patient access to Chlamydia screening, and thus the number of reported cases, varies substantially between countries. In some countries annual screening is recommended for specific patient groups deemed to be at higher risk of contracting the disease, such as sexually active females younger than 25 years. Additionally, screening of pregnant women for Chlamydia Trachomatis infections is currently recomme......	$7500
EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Globally, lung cancer is the second most common cancer in men and the third most common cancer in women. There are two main types of lung cancer; small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), with NSCLC accounting for approximately 80-90% of all lung cancer cases. The 5-year survival rate for patients with stage IV disease is less than 5% as majority of patients present with the advanced or metastatic disease at diagnosis. EGFR is a member of the receptor tyrosine kinase family and a major factor in regulating ......	$7500
Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cervical cancer screening has traditionally been based on cervical cytology. In recent years however, many countries have incorporated Human Papilloma Virus (HPV) tests into their cervical cancer and pre-cancer screening programs. Cytology based screening programs require a well-established healthcare infrastructure for processing and interpretation of samples. It is hoped that HPV screening methods may enable better prevention of these disease, these devices are also highly sensitive an......	$7500
Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model "Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cytomegalovirus (CMV) represents the most common congenital, viral infection in the developed world and awareness of this disease is increasing. Few countries have official guidelines in place for CMV screening but in general testing tends to be performed for sperm donations, immunocompromised cases, and pregnant women. Diagnosis of CMV infections is complex as symptoms are often non-specific and mimic mononucleosis or the flu. Approximately 21-25% of primary CMV infections are symptomatic ......	$7500
Prenatal Screening (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Prenatal Screening (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Prenatal Screening (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Prenatal Screening is now routinely used in developed countries for early detection of fetal abnormalities. Various biochemical analytes are measured during the first or second trimester including free-beta human chorionic gonadotropin (hCG), total hCG, pregnancy associated plasma protein-A (PAPP-A), Alpha-fetoprotein (AFP), unconjugated estriol (uE3), and Inhibin A. These markers are used to screen for Down syndrome (Trisomy 21) as well as Edwards syndrome (Trisomy 18) and ectopic pregnancy. Additionally, maternal s......	$7500

North America Clinical Chemistry Market Outlook to 2024

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026

Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact)

Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact)

Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028

Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Prenatal Screening (In Vitro Diagnostics) – Global Market Analysis and Forecast Model